Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release

Blood

Volumn 99, Issue 2, 2002, Pages 655-663

  Chandra, Joya ^a,b   Mansson, Emma ^a   Gogvadze, Vladimir ^a   Kaufmann, Scott H ^a   Albertioni, Freidoun ^a   Orrenius, Sten ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE DERIVATIVE; CALCIUM; CASPASE; CASPASE 3; CASPASE 9; CLADRIBINE; CYTOCHROME C; DEOXYCYTIDINE KINASE; DNA FRAGMENT; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FAS ANTIGEN; PROTEIN BCL 2; PURINE NUCLEOSIDE; STAUROSPORINE; THAPSIGARGIN;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CROSS RESISTANCE; CYTOSOL; DRUG ACCUMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL;

EID: 0037079699     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.655     Document Type: Article

References (39)

1. The treatment of chronic progressive multiple sclerosis with cladribine
2. Nucleoside analogs in treatment of chronic lymphocytic leukemia
3. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes
4. Pharmacology of purine nucleoside analogues
5. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine
6. Caspases: Enemies within
7. Biochemical pathways of caspase activation during apoptosis
8. Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway
9. The mitochondrial permeability transition
10. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis
11. Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes
12. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells
13. Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei
14. Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues
15. Liquid chromatographic study of acid stability of 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, 2-chloro-2′-deoxyadenosine and related analogues
16. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
17. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
18. Distinct pathways for stimulation of cytochrome c release by etoposide
19. Mitochondrial permeability transition is a central coordinating event of apoptosis
20. Injected cytochrome c induces apoptosis
21. Bcl-2 family proteins as ion-channels
22. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
23. 2+ signals activate apoptosis in thymocytes: Studies using the Ca(2+)-ATPase inhibitor thapsigargin
24. Relationship of deoxycytidine kinase and cytoplasmic 5′-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine
25. Pharmacokinetics of cladribine in plasma and its 5′-monophosphate and 5′-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia
26. Cloning and expression of human deoxyguanosine kinase cDNA
27. Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines
28. 2-Chloro-2′-deoxyadenosine, an antileukemic drug, has an early effect on cellular mitochondrial function
29. Induction of human high K(M) 5′-nucleotidase in cultured 293 cells
30. Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c
31. Involvement of the CD95 (APO-I/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells
32. 2-Chloro-2′-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4
33. Inhibition of FAS/FAS-ligand does not block chemotherapy-induced apoptosis in drug sensitive and resistant cells
34. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system
35. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria
36. Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy
37. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3
38. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD
39. Bax cleavage is mediated by calpain during drug-induced apoptosis